# The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-dpp-4-inhibitor-sitagliptin-attenuates-the-progress-of-atherosclerosis-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yanmei Zeng,Chenzhong Li,Meiping Guan,Zongji Zheng,Jingjing Li,Wen-Wei Xu,Ling Wang,Feiying He,Yaoming Xue |
| Citations | 121 |
| DOI | 10.1186/1475-2840-13-32 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://cardiab.biomedcentral.com/counter/pdf/10.1186/1475-2840-13-32 |
| OpenAlex ID | https://openalex.org/W2110317359 |
| PMID | 24490809 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Yaoming Xue](https://scholariq.org/researchers/yaoming-xue/)

## Paper journal

- [Cardiovascular Diabetology](https://scholariq.org/journals/cardiovascular-diabetology/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.